Cara Therapeutics (0HTC.L) Stock Price
$5.33 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Cara Therapeutics, AI stock picks, stock alerts and much more.
0HTC.L AI Stock Analysis
AI stock analysis for 0HTC.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cara Therapeutics (0HTC.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Cara Therapeutics (0HTC.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cara Therapeutics (0HTC.L), currently trading at $5.33, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0HTC.L
-
Cara Therapeutics, Inc.
-
Symbol
0HTC.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
17.7M
Similar Stocks
 |
Waters Corporation 0LTI.L |
$322.5 2.6% |
6 |
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$490.2 0% |
5 |
 |
Neurocrine Biosciences 0K6R.L |
$100.6 1.7% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$4.66 2.4% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$4.91 1.4% |
5 |
News
0HTC.L Alternative Data
Web Traffic
Cara Therapeutics receives an estimated 3489 monthly visitors to caratherapeutics.com.
-
Web Traffic
3489
-
Change from Previous Month
32.6%
-
3 Month Change
45.3%
-
YoY Change
45.3%
News Mentions
Cara Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Instagram Followers
Cara Therapeutics has 146 Instagram Followers on its main Instagram account.
-
Instagram Followers
146
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.4%
Youtube Subscribers
Cara Therapeutics has 31 subscribers on its main Youtube channel.
-
Youtube Subscribers
31
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Cara Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Cara Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Cara Therapeutics has 161 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.6% over the last month.
-
Twitter Followers
161
-
Daily Change
0.6%
-
1 Month Change
0.6%
-
3 Month Change
0.6%
LinkedIn Followers
6,300 are following Cara Therapeutics on LinkedIn, up by 0.4% over the last month.
-
LinkedIn Followers
6300
-
Daily Change
0.1%
-
1 Month Change
0.4%
-
3 Month Change
1.7%
LinkedIn Employees
According to LinkedIn, Cara Therapeutics has 42 employees.
-
LinkedIn Employees
42
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
8.7%
Business Outlook
According to employee reviews, the business outlook among employees at Cara Therapeutics is 65 out of 100 (bullish).
-
Business Outlook
65
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
0HTC.L Financials
0HTC.L Key Metrics
-
Total Revenue
$1.5M
-
Net Income
-$7.7M
-
Earnings per Share
-$0.23
-
Free cash flow
-$4M
-
EBITDA
-$5.5M
-
EBITDA Ratio
-3.74983
-
Total Assets
$43.8M
0HTC.L 2-year Revenue & Income
0HTC.L 2-year Free Cash Flow
0HTC.L Technicals
0HTC.L SMA
0HTC.L RSI
FAQ
What's the current price of Cara Therapeutics (0HTC.L) Stock?
The price of an Cara Therapeutics (0HTC.L) share is $5.33.
What's the market cap of Cara Therapeutics?
The current market cap of Cara Therapeutics is 17.7M.
Should I buy or sell 0HTC.L?
Cara Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Cara Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Cara Therapeutics a good investment?
The current analysis of Cara Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Cara Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Cara Therapeutics (0HTC.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Cara Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Cara Therapeutics (0HTC.L) that investors often compare it to?
Cara Therapeutics (0HTC.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc. and Abeona Therapeutics Inc..
What is the forecast for Cara Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cara Therapeutics' stock price to be around $5.04 in 2026. Starting from the current price of $5.33, this represents a 5.4% change in price, indicating a bearish outlook for the stock.
How to buy Cara Therapeutics (0HTC.L) Stock?
Cara Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cara Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.